B. Riley Wealth Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $364 | Buy |
1,107
+200
| +22% | +$66 | ﹤0.01% | 486 |
|
|
2022
Q1 | $397K | Sell |
907
-3
| -0.3% | -$1.31K | 0.03% | 378 |
|
|
2021
Q4 | $399K | Sell |
910
-42
| -4% | -$18.4K | 0.03% | 397 |
|
|
2021
Q3 | $529K | Buy |
+952
| New | +$529K | 0.04% | 321 |
|
|
2020
Q3 | – | Sell |
-831
| Closed | -$512K | – | 545 |
|
|
2020
Q2 | $512K | Sell |
831
-147
| -15% | -$90.6K | 0.06% | 227 |
|
|
2020
Q1 | $465K | Buy |
978
+65
| +7% | +$30.9K | 0.05% | 277 |
|
|
2019
Q4 | $530K | Sell |
913
-2
| -0.2% | -$1.16K | 0.08% | 207 |
|
|
2019
Q3 | $602K | Sell |
915
-19
| -2% | -$12.5K | 0.11% | 184 |
|
|
2019
Q2 | $723 | Sell |
934
-4
| -0.4% | -$3 | 0.11% | 169 |
|
|
2019
Q1 | $662K | Sell |
938
-42
| -4% | -$29.6K | 0.11% | 177 |
|
|
2018
Q4 | $459K | Sell |
980
-43
| -4% | -$20.1K | 0.1% | 189 |
|
|
2018
Q3 | $882K | Buy |
+1,023
| New | +$882K | 0.22% | 107 |
|
|
2015
Q3 | – | Sell |
-13
| Closed | -$5K | – | 783 |
|
|
2015
Q2 | $5K | Buy |
+13
| New | +$5K | ﹤0.01% | 867 |
|